The newest expert to join the Translational Sciences team, Dr. Corinna Fiorotti brings almost two decades of drug development experience in large pharma/biotech which spans from research through clinical development, with expertise in building and executing on strategies for bioanalytical development. Dr. Fiorotti holds a Ph.D. in Immunology and Microbiology and completed a post-doctoral fellowship in Molecular Biology at Harvard Medical School where her work was featured as a cover story in the journal Nature. Dr. Fiorotti has deep knowledge in immunogenicity and bioanalytical assays which cover a wide range of disease areas and therapeutic modalities including protein therapeutics, and cell and gene therapy. She has extensive expertise in cell-based assays in addition to developing ADA and PK assays for both pre-clinical and clinical support. Dr. Fiorotti has an exceptional track record working with project teams to identify the critical questions/decision points and delivering strategies to address them, leading to efficient prosecution of their programs. Dr. Fiorotti has a wide global footprint and is an invited speaker at bioanalytical focused meetings.